Rapid European SARS-CoV-2 Emergency research Response

Resultado final

2-Reports on the coordinated development and operational management of the European COVID-19 Adaptive Platform Trials

This report will include but is not limited to key recommendations to implement the highlevel strategy defined by the TCB development of new platforms major amendments to existing platforms introduction of new therapeutic domains introduction of new arms development of platforms for prevention or vaccines design of interventional trials based on observational studies expansion to new countries including capacity building for interested sites site selection etc The report will describe the framework that will allow complementarity between trials with regard to the implementation of the highlevel strategy This report will also include the detailed plan on data harmonization between trials to allow common analysis of core data sets

Plan for coordination and collaboration with other SARS-COV-2 projects: update 1

First update of D13

SOPs to standardise and harmonise diagnostic test protocols

SOPs to standardise and harmonise diagnostic test protocols for detection of the SARS-CoV-2 and/or exclusion of other respiratory viral and bacterial pathogens.

Final report on the readiness of the networks

Report on the additional qualitative work on the readiness of the networks

Protocol for healthcare professionals survey

Understanding healthcare worker views on the management of the COVID-19 pandemic can inform hospital strategies for implementing IPC guidelines, inform communication strategies and can inform strategies to protect healthcare worker physical and psychological health.

1-Reports on the coordinated development and operational management of the European COVID-19 Adaptive Platform Trials

This report will include, but is not limited to key recommendations to implement the high-level strategy defined by the TCB - development of new platforms, major amendments to existing platforms, introduction of new therapeutic domains, introduction of new arms, development of platforms for prevention or vaccines, design of interventional trials based on observational studies, expansion to new countries including capacity building for interested sites, site selection etc. The report will describe the framework that will allow complementarity between trials with regard to the implementation of the high-level strategy. This report will also include the detailed plan on data harmonization between trials to allow common analysis of core data sets.

2-Report on the strategic vision and deployment of the European COVID-19 Adaptive Platform Trials

This report will include but is not limited to COVID19 international clinical research benchmarking and landscape analysis clinical research gaps for Europe recommendations on priorities in terms of platform trials therapeutic domains and arms It will also include a report on lessonslearnt from OCToPUs

First study report of finalized analysis in one treatment domain
Study updates and summaries

Regular study updates will allow to keep all partners informed about study progress Dates of publication cannot be specified as patient enrollment depends on the evolution of the pandemic

Plan for coordination and collaboration with other SARS-COV-2 projects: update 2

Second update of D13

UK approved protocol for adapted PRUDENCE trial

RECOVER will seek rapid UK approval of the protocol governing the adapted PRUDENCE trial as originally developed in the VALUEDx project

Healthcare professionals survey report

Interview approaches will be pragmatic and adapted to consider the immediate needs of healthcare professionals and to minimise burden.

1-Report on the strategic vision and deployment of the European COVID-19 Adaptive Platform Trials

This report will include, but is not limited to COVID-19 international clinical research benchmarking and landscape analysis, clinical research gaps for Europe, recommendations on priorities in terms of platform trials, therapeutic domains and arms. It will also include a report on lessons-learnt from OCToPUs.

Plan for coordination and collaboration with other SARS-COV-2 projects

Report to include plan for regular meetings to update on each other's progress, concrete plan on use of common protocols and to ensure harmonization of data collection and coordinated modelling, establishment of inter-project working groups, plan on integration of social sciences capacities and sharing research findings on the dedicated platform (Health Policy Platform/research for policy action).

Results of etiologic diagnosis

Results of etiologic diagnosis on the samples from patients included in the clinical trials on the SARS-CoV-2 in WP2 and WP3.

Final study report
Feasibility questionnaire

To facilitate the site selection process, a feasibility questionnaire will be sent that aims to collect study-specific information e.g. on in-house methods and possibilities to implement protocols and methods to detect SARS-COV-2.

Validation report on PCR based test

Validation report on ready-to-use in-house PCR based test to be used in the clinical trial.

Approved protocol for the observational study

This protocol for a prospective, non-randomized observational study of CA-ARTI in primary care will include capability to register patients with CA-ARTI in primary care in up to 20 countries, capturing data about the presentation, management, risk factors and (reasons for) suspicion for SARS-CoV-2, treatment, routine investigations performed, outcome of tests, taking a throat and/or nasal swab for research purposes, and capturing clinical outcomes and patient and HCP perceptions.

Monthly interim findings from social science related activities

In order to rapidly generate evidence for public health and other decision makers, RECOVER will include a brief survey for patients and healthcare workers. Information will be rapidly processed and interim findings fed back to decision makers.

Policy brief reporting outcomes from the public survey

Interim reports will help guide communication strategies and clinical research planning at local and national levels

Communication outputs

We will share our (preliminary) results with public health authorities, policy makers and healthcare workers via regular policy briefs and healthcare briefs, summarizing our findings in a concise manner. There is a wealth of other research response efforts being implemented by the wider European infectious diseases research response community. Many of our partners working in Europe, but also in regions outside of Europe (e.g. Africa and Asia) have informed us of their efforts and offered linking their efforts to those conducted in RECOVER. We will reach out to patient organisations such as the International Alliance of Patients’ Organisations (IAPO and European Lung Foundation (ELF) to assess their information needs and how we can best serve these out of RECOVER. RECOVER will target the media with press releases at important time points and milestones. RECOVER's communication activities include the design of a visual identity, online presence (website, social media...), open access publications, news updates, infographics and brochures.

Study protocol MERMAIDS 2.0

For Phase II, we will adapt the existing MERMAIDS-ARI protocol (part I) to capture additional aspects relevant to SARS-CoV-2 infections, collect more and targeted biological sampling of confirmed SARS-CoV-2 infections needed for WP5 and WP6, and to enroll children (non-eligible in part I).

Second overall study report
Report on tools, methodologies and sustainability model for Adaptive Platform Trial design and management, including blueprint for the creation and management of Adaptive Platform Trials in other disease areas beyond COVID-19

This report will include but is not limited to tools for the design of platform trials including statistical methods master protocol template selection of outcome measures and endpoints etc tools for the management of platform trials including sponsorship IP pharmacovigilance data management data sharing cost and business model etc

Protocols for collection and transport of specimens

This deliverable includes sampling SOPs with details on the choice of samples and sampling collection time points that should be collected in line with the study objectives and SOPs with detailed instructions on sample processing locally, storage and transfer of samples to the central laboratory.

Final study report on social science

Final study report on the social science output

Publicaciones

Population-based screening in a municipality after a primary school outbreak of the SARS-CoV-2 Alpha variant, the Netherlands, December 2020–February 2021

Autores: van Beek et al
Publicado en: PLOS One, 2022
Editor: PLOS
DOI: 10.1371/journal.pone.0276696

Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modelling study

Autores: De Meijere et al.
Publicado en: The Lancet Regional Health - Europe, 2023
Editor: Elsevier
DOI: 10.1016/j.lanepe.2023.100614

Conducting rapid qualitative interview research during the COVID-19 pandemic—Reflections on methodological choices

Autores: Marta Wanat, Aleksandra J. Borek, Caitlin Pilbeam, Sibyl Anthierens, and Sarah Tonkin-Crine
Publicado en: Frontiers in Sociology, 2022
Editor: Frontiers
DOI: 10.3389/fsoc.2022.953872

Highlighting socio-economic constraints on mobility reductions during COVID-19 restrictions in France can inform effective and equitable pandemic response

Autores: Eugenio Valdano, Jonggul Lee, Shweta Bansal, Stefania Rubrichi, Vittoria Colizza
Publicado en: Journal of Travel Medicine, 2021
Editor: Oxford Academic
DOI: 10.1093/jtm/taab045

Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the ISARIC WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study

Autores: Reyes, Luis Felipe et al
Publicado en: ERJ Open Research, 2022
Editor: ERS
DOI: 10.1183/23120541.00552-2021

Conformational dynamics of the Beta and Kappa SARS-CoV-2 spike proteins and their complexes with ACE2 receptor revealed by cryo-EM

Autores: Yifan Wang, Cong Xu, Yanxing Wang, Qin Hong, Chao Zhang, Zuyang Li, Shiqi Xu, Qinyu Zuo, Caixuan Liu, Zhong Huang, Yao Cong
Publicado en: Nature Communications, Edición Article number: 7345 (2021), 2021
Editor: Springer Nature
DOI: 10.1038/s41467-021-27350-0

Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients

Autores: GeurtsvanKessel CH, Geers D, Schmitz KS, Mykytyn AZ, Lamers MM, Bogers S, Scherbeijn S, Gommers L, Sablerolles RSG, Nieuwkoop NN, Rijsbergen LC, van Dijk LLA, de Wilde J, Alblas K, Breugem TI, Rijnders BJA, de Jager H, Weiskopf D, van der Kuy PHM, Sette A, Koopmans MPG, Grifoni A, Haagmans BL, de Vries RD
Publicado en: Sci Immunol, 2022
Editor: AAAS
DOI: 10.1126/sciimmunol.abo2202

Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta

Autores: Ulrich L, Halwe NJ, Taddeo A, Ebert N, Schön J, Devisme C, Trüeb BS, Hoffmann B, Wider M, Fan X, Bekliz M, Essaidi-Laziosi M, Schmidt ML, Niemeyer D, Corman VM, Kraft A, Godel A, Laloli L, Kelly JN, Calderon BM, Breithaupt A, Wylezich C, Berenguer Veiga I, Gultom M, Osman S, Zhou B, Adea K, Meyer B, Eberhardt CS, Thomann L, Gsell M, Labroussaa F, Jores J, Summerfield A, Drosten C, Eckerle IA, We
Publicado en: Nature, 2022
Editor: Springer Nature
DOI: 10.1038/s41586-021-04342-0

The value of open-source clinical science in pandemic response: lessons from ISARIC

Autores: The ISARIC Clinical Characterisation Group
Publicado en: Lancet Infectious Diseases, 2021
Editor: Elsevier
DOI: 10.1016/s1473-3099(21)00565-x

Methodological and ethical considerations when conducting qualitative interview research with healthcare professionals: reflections and recommendations as a result of a pandemic

Autores: Pilbeam, C., Anthierens, S., Vanderslott, S., Tonkin-Crine, S., & Wanat, M.
Publicado en: International Journal of Qualitative Methods, 2022
Editor: Sage Journals
DOI: 10.1177/16094069221077763

Transmission of SARS-CoV-2 within households: a remote prospective cohort study in European countries

Autores: Janneke D. M. Verberk, Marieke L. A. de Hoog, Ilse Westerhof, Sam van Goethem, Christine Lammens, Greet Ieven, Erwin de Bruin, Dirk Eggink, Julia A. Bielicki, Samuel Coenen, Janko van Beek, Marc J. M. Bonten, Herman Goossens & Patricia C. J. L. Bruijning-Verhagen
Publicado en: European Journal of Epidemiology, 2022
Editor: Springer
DOI: 10.1007/s10654-022-00870-9

Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.

Autores: Ewan C. Goligher, Patrick R. Lawler, Thomas P. Jensen, et al
Publicado en: JAMA, 2023
Editor: JAMA Network
DOI: 10.1001/jama.2023.3651

Monitoring key epidemiological parameters of SARS-CoV-2 transmission

Autores: Kraemer MUG, Pybus OG, Fraser C, Cauchemez S, Rambaut A, Cowling BJ
Publicado en: Nature Medicine, 2021
Editor: Springer Nature
DOI: 10.1038/s41591-021-01545-w

Modelling COVID-19 in school settings to evaluate prevention and control protocols

Autores: Colosi et al.
Publicado en: Anaesthesia Critical Care & Pain Medicine, 2022
Editor: Science Direct
DOI: 10.1016/j.accpm.2022.101047

Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalization and serological data: a modelling study

Autores: Hoze N, Paireau J, Lapidus N, Tran Kiem C, Salje H, Severi G, Touvier M, Zins M, de Lamballerie X, Lévy-Bruhl D, Carrat F, Cauchemez S
Publicado en: Lancet Public Health, 2021
Editor: Elsevier
DOI: 10.1016/s2468-2667(21)00064-5

Early assessment of diffusion and possible expansion of SARS-CoV-2 lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021

Autores: Gaymard A, Bosetti P, Feri A, Destras G, Enouf V, Andronico A, Burrel S, Behillil S, Sauvage C, Bal A, Morfin F, Van Der Werf S, Josset L, ANRS MIE AC43 COVID-19, French viro COVID group, Blanquart F, Coignard B, Cauchemez S, Lina B
Publicado en: Eurosurveillance, 2021
Editor: Eurosurveillance
DOI: 10.2807/1560-7917.es.2021.26.9.2100133

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

Autores: Reincke SM, Yuan M, Kornau HC, Corman VM, van Hoof S, Sánchez-Sendin E, Ramberger M, Yu W, Hua Y, Tien H, Schmidt ML, Schwarz T, Jeworowski LM, Brandl SE, Rasmussen HF, Homeyer MA, Stöffler L, Barner M, Kunkel D, Huo S, Horler J, von Wardenburg N, Kroidl I, Eser TM, Wieser A, Geldmacher C, Hoelscher M, Gänzer H, Weiss G, Schmitz D, Drosten C, Prüss H, Wilson IA, Kreye J
Publicado en: Science, 2022
Editor: AAAS
DOI: 10.1126/science.abm5835

Investigations on SARS-CoV-2 and other coronaviruses in mink farms in France at the end of the first year of COVID-19 pandemic.

Autores: Wasniewski M, Boué F, Richomme C, Simon-Lorière E, Van der Werf S, Donati F, Enouf V, Blanchard Y, Beven V, Leperchois E, Leterrier B, Corbet S, Le Gouil M, Monchatre-Leroy E, Picard-Meyer E.
Publicado en: bioRxiv, 2023
Editor: preprint
DOI: 10.1101/2023.02.02.526749

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

Autores: Writing Committee for the REMAP-CAP Investigators
Publicado en: JAMA, 2022
Editor: JAMA Network
DOI: 10.1001/jama.2022.23257

A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern

Autores: van Gils MJ, van Willigen HDG, Wynberg E, Han AX, van der Straten K, Burger JA, Poniman M, Oomen M, Tejjani K, Bouhuijs JH, Verveen A, Lebbink R, Dijkstra M, Appelman B, Lavell AHA, Caniels TG, Bontjer I, van Vught LA, Vlaar APJ, Sikkens JJ, Bomers MK, Russell CA, Kootstra NA, Sanders RW, Prins M, de Bree GJ, de Jong MD
Publicado en: Cell Rep Med, 2021
Editor: Elsevier
DOI: 10.1016/j.xcrm.2021.100486

Impact of contact data resolution on the evaluation of interventions in mathematical models of infectious diseases

Autores: Contreras et al.
Publicado en: Journal of the Royal Society, 2022
Editor: Royal Society Publishing
DOI: 10.1098/rsif.2022.0164

Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis

Autores: Peter J. Godolphin, David J. Fisher, Lindsay R. Berry, Lennie P. G. Derde, Janet V. Diaz, Anthony C. Gordon, Elizabeth Lorenzi, John C. Marshall, Srinivas Murthy, Manu Shankar-Hari, Jonathan A. C. Sterne, Jayne F. Tierney, Claire L. Vale
Publicado en: Plos One, 2022
Editor: PLOS
DOI: 10.1371/journal.pone.0270668

Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France

Autores: Laura Di Domenico, Chiara E Sabbatini, Giulia Pullano, Daniel Lévy-Bruhl, Vittoria Colizza
Publicado en: Eurosurveillance, 2021
Editor: Eurosurveillance
DOI: 10.2807/1560-7917.es.2021.26.15.2100272

Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination

Autores: Loyal L, Braun J, Henze L, Kruse B, Dingeldey M, Reimer U, Kern F, Schwarz T, Mangold M, Unger C, Dörfler F, Kadler S, Rosowski J, Gürcan K, Uyar-Aydin Z, Frentsch M, Kurth F, Schnatbaum K, Eckey M, Hippenstiel S, Hocke A, Müller MA, Sawitzki B, Miltenyi S, Paul F, Mall MA, Wenschuh H, Voigt S, Drosten C, Lauster R, Lachman N, Sander LE, Corman VM, Röhmel J, Meyer-Arndt L, Thiel A, Giesecke-Th
Publicado en: Science, 2021
Editor: AAAS
DOI: 10.1126/science.abh1823

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.

Autores: Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J, Bolland WH, Porrot F, Staropoli I, Lemoine F, Péré H, Veyer D, Puech J, Rodary J, Baele G, Dellicour S, Raymenants J, Gorissen S, Geenen C, Vanmechelen B, Wawina-Bokalanga T, Martí-Carreras J, Cuypers L, Sève A, Hocqueloux L, Prazuck T, Rey FA, Simon-Loriere E, Bruel T, Mouquet H, André E, Schwartz O.
Publicado en: Nature, 2022
Editor: nature
DOI: 10.1038/s41586-021-04389-z

Projecting the COVID-19 epidemic risk in France for the summer 2021

Autores: Mattia Mazzoli, Eugenio Valdano, Vittoria Colizza
Publicado en: Journal of travel medicine, 2021
Editor: Oxford Academic
DOI: 10.1093/jtm/taab129

Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis

Autores: Lefrancq N, Paireau J, Hozé N, Courtejoie N, Yazdanpanah Y, Bouadma L, Boëlle PY, Chereau F, Salje H, Cauchemez S
Publicado en: The Lancet Regional Health - Europe, 2021
Editor: Elsevier
DOI: 10.1016/j.lanepe.2021.100087

Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021

Autores: Tober-Lau P, Schwarz T, Hillus D, Spieckermann J, Helbig ET, Lippert LJ, Thibeault C, Koch W, Bergfeld L, Niemeyer D, Mühlemann B, Conrad C, Kasper S, Münn F, Kunitz F, Jones TC, Suttorp N, Drosten C, Sander LE, Kurth F, Corman VM
Publicado en: Emerg Infect Dis, 2021
Editor: CDC
DOI: 10.3201/eid2708.210887

Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort

Autores: ISARIC Clinical Characterisation Group et al
Publicado en: eLife, 2021
Editor: eLife
DOI: 10.7554/elife.70970

SARS-CoV-2 transmission across age groups in France and implications for control

Autores: Tran Kiem C, Bosetti P, Paireau J, Crepey P, Salje H, Lefrancq N, Fontanet A, Benamouzig D, Boelle PY, Desenclos JC, Opatowski L, Cauchemez S
Publicado en: Nature Communications, 2021
Editor: Springer Nature
DOI: 10.1038/s41467-021-27163-1

Screening and vaccination against COVID-19 to minimise school closure: a modelling study

Autores: Colosi et al
Publicado en: The Lancet Infectious Diseases, 2022
Editor: Science Direct
DOI: 10.1016/s1473-3099(22)00138-4

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

Autores: T. Asano et al
Publicado en: Science Immunology, 2021
Editor: AAAS
DOI: 10.1126/sciimmunol.abl4348

The experiences of patients ill with COVID-19-like symptoms and the role of testing for SARS-CoV-2 in supporting them: A qualitative study in eight European countries during the first wave of the pandemic

Autores: Hoste ME, Wanat M, Gobat N, et al.
Publicado en: European Journal of General Practice, 2023
Editor: Taylor and Francis
DOI: 10.1080/13814788.2023.2212904

Drivers and impact of the early silent invasion of SARS-CoV-2 Alpha

Autores: Faucher et al.
Publicado en: 2023
Editor: MedrXiv
DOI: 10.1101/2023.08.21.23293488

High incidence of sotrovimab resistance and viral persistence after treatment of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

Autores: Huygens et al
Publicado en: Clinical Infectious Diseases, 2022
Editor: Oxford Academic
DOI: 10.1093/cid/ciac601

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.

Autores: Writing Committee for the REMAP-CAP Investigators
Publicado en: JAMA, 2023
Editor: JAMA Network
DOI: 10.1001/jama.2023.4480

Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany

Autores: Schwarz T, Tober-Lau P, Hillus D, Helbig ET, Lippert LJ, Thibeault C, Koch W, Landgraf I, Michel J, Bergfeld L, Niemeyer D, Mühlemann B, Conrad C, Dang-Heine C, Kasper S, Münn F, Kappert K, Nitsche A, Tauber R, Schmidt S, Kopankiewicz P, Bias H, Seybold J, von Kalle C, Jones TC, Suttorp N, Drosten C, Sander LE, Corman VM, Kurth F
Publicado en: Emerg Infect Dis, 2021
Editor: CDC
DOI: 10.3201/eid2708.211145

The experience of European hospital-based health care workers on following infection prevention and control procedures and their well-being during the first wave of the COVID-19 pandemic

Autores: Denise van Hout, Paul Hutchinson, Marta Wanat, Caitlin Pilbeam, Herman Goossens, Sibyl Anthierens, Sarah Tonkin-Crine, Nina Gobat
Publicado en: PLoS ONE, 2022
Editor: PLoS ONE
DOI: 10.1371/journal.pone.0245182

Analysis of Severe Acute Respiratory Syndrome 2 Replication in Explant Cultures of the Human Upper Respiratory Tract Reveals Broad Tissue Tropism of Wild-Type and B.1.1.7 Variant Viruses

Autores: Schulze, J., Mache, C., Balázs, A., Frey, D., Niemeyer, D., Olze, H., Dommerich, S., Drosten, C., Hocke, A. C., Mall, M. A., Hippenstiel, S., & Wolff, T
Publicado en: The Journal of infectious diseases, 2021
Editor: Oxford Academic
DOI: 10.1093/infdis/jiab523

The European clinical research response to optimise treatment of patients with COVID-19: lessons learned, future perspective, and recommendations

Autores: Goossens H, Horby P, Derde L, Bonten M
Publicado en: Lancet Infect Dis, 2021
Editor: The Lancet
DOI: 10.1016/s1473-3099(21)00705-2

Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France

Autores: Bosetti P, Tran Kiem C, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, Cauchemez S
Publicado en: Eurosurveillance, 2021
Editor: Eurosurveillance
DOI: 10.2807/1560-7917.es.2020.26.1.2001978

Conditionality of COVID-19 vaccine acceptance in European countries

Autores: Leonardo W. Heyerdahl, Muriel Vray, Benedetta Lana, Nastassia Tvardik, Nina Gobat, Marta Wanat, Sarah Tonkin-Crine, Sibyl Anthierens, Herman Goossens, Tamara Giles-Vernick
Publicado en: Vaccine, 2022
Editor: Elsevier
DOI: 10.1016/j.vaccine.2022.01.054

Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna

Autores: Brault et al
Publicado en: The Lancet Regional Health, 2023
Editor: Elsevier
DOI: 10.1016/j.lanwpc.2022.100634

An early warning system for emerging SARS-CoV-2 variants

Autores: Subissi L, von Gottberg A, Thukral L, Worp N, Oude Munnink BB, Rathore S, Abu-Raddad LJ, Aguilera X, Alm E, Archer BN, Attar Cohen H, Barakat A, Barclay WS, Bhiman JN, Caly L, Chand M, Chen M, Cullinane A, de Oliveira T, Drosten C, Druce J, Effler P, El Masry I, Faye A, Gaseitsiwe S, Ghedin E, Grant R, Haagmans BL, Herring BL, Iyer SS, Kassamali Z, Kakkar M, Kondor RJ, Leite JA, Leo YS, Leung GM,
Publicado en: Nature Medicine, 2022
Editor: Nature
DOI: 10.1038/s41591-022-01836-w

Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2.

Autores: Saunders N, Planas D, Bolland WH, Rodriguez C, Fourati S, Buchrieser J, Planchais C, Prot M, Staropoli I, Guivel-Benhassine F, Porrot F, Veyer D, Péré H, Robillard N, Saliba M, Baidaliuk A, Seve A, Hocqueloux L, Prazuck T, Rey FA, Mouquet H, Simon-Lorière E, Bruel T, Pawlotsky JM, Schwartz O.
Publicado en: 2022
Editor: Science Direct
DOI: 10.1016/j.ebiom.2022.103934

Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19

Autores: Aguilar-Bretones M, Westerhuis BM, Raadsen MP, de Bruin E, Chandler FD, Okba NM, Haagmans BL, Langerak T, Endeman H, van den Akker JP, Gommers DA, van Gorp EC, GeurtsvanKessel CH, de Vries RD, Fouchier RA, Rockx BH, Koopmans MP, van Nierop GP
Publicado en: The Journal of Clinical Investigation, 2021
Editor: ASCI
DOI: 10.1172/jci150613

Continuation of therapeutic dose heparin for critically ill patients with COVID-19.

Autores: Charlotte A. Bradbury, Patrick R. Lawler, Bryan J. McVerry & Ryan Zarychanski on behalf of the REMAP-C. A. P. Investigators
Publicado en: Intensive care medicine, 2023
Editor: Springer
DOI: 10.1007/s00134-023-07095-8

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.

Autores: Planchais C, Fernández I, Bruel T, de Melo GD, Prot M, Beretta M, Guardado-Calvo P, Dufloo J, Molinos-Albert LM, Backovic M, Chiaravalli J, Giraud E, Vesin B, Conquet L, Grzelak L, Planas D, Staropoli I, Guivel-Benhassine F, Hieu T, Boullé M, Cervantes-Gonzalez M, Ungeheuer MN, Charneau P, van der Werf S, Agou F; French COVID Cohort Study Group; CORSER Study Group; Dimitrov JD, Simon-Lorière E,
Publicado en: Journal of Experimental Medicine, 2022
Editor: Rockefeller University Press
DOI: 10.1084/jem.20220638

Minimising school disruption under high incidence conditions due to the Omicron variant in France, Switzerland, Italy, in January 2022.

Autores: Colosi et. al.
Publicado en: Eurosurveillance, 2022
Editor: Eurosurveillance
DOI: 10.2807/1560-7917.es.2023.28.5.2200192

Regular universal screening for SARS-CoV-2 infection may not allow reopening of society after controlling a pandemic wave

Autores: MCJ Bootsma, ME Kretzschmar, G Rozhnova, JAP Heesterbeek, JAJW Kluytmans, MJM Bonten
Publicado en: medrxiv, Edición Preprint server, 2020
Editor: BMJ
DOI: 10.1101/2020.11.18.20233122

Platform trials as the way forward in infectious disease' clinical research: the case of coronavirus disease 2019

Autores: Juan M. Pericas, Lennie P.G. Derde, Scott M. Berry, on behalf of EU-PEARL and REMAP-CAP investigators
Publicado en: Clinical Microbiology and Infection, 2023
Editor: Elsevier
DOI: 10.1016/j.cmi.2022.11.022

Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibody

Autores: 39. Li T, Cai H, Zhao Y, Li Y, Lai Y, Yao H, Liu LD, Sun Z, van Vlissingen MF, Kuiken T, GeurtsvanKessel CH, Zhang N, Zhou B, Lu L, Gong Y, Qin W, Mondal M, Duan B, Xu S, Richard AS, Raoul H, Chen J, Xu C, Wu L, Zhou H, Huang Z, Zhang X, Li J, Wang Y, Bi Y, Rockx B, Chen J, Meng FL, Lavillette D, Li D
Publicado en: EMBO Molecular Medicine, 2021
Editor: EMBOpress
DOI: 10.15252/emmm.202114544

Prospective SARS-CoV-2 cohort study among primary health care providers during the second COVID-19 wave in Flanders, Belgium

Autores: Mariën, J., Ceulemans A., Bakokimi D, Lammens C., Ieven M., Heytens S., De Sutter A., Verbakel, J. Y., Van den Bruel A., Goossens H., Van Damme P., Arië, K. K. , and Coenen S.
Publicado en: Family Practice, 2022
Editor: Oxford Academic
DOI: 10.1093/fampra/cmab094

Rapid characterization of a Delta-Omicron SARS-CoV-2 recombinant detected in Europe

Autores: Simon-Loriere et al
Publicado en: preprint, 2022
Editor: Researchsquare
DOI: 10.21203/rs.3.rs-1502293/v1

The impact of variant and vaccination on SARS-CoV-2 symptomatology; three prospective household cohorts

Autores: Ilse Westerhof, Marieke de Hoog, Margareta Ieven, Christine Lammens, Janko van Beek, Ganna Rozhnova, Dirk Eggink, Sjoerd Euser, Joanne Wildenbeest, Liesbeth Duijts, Marlies van Houten, Herman Goossens, Carlo Giaquinto, Patricia Bruijning–Verhagen
Publicado en: International Journal of Infectious Diseases, 2023
Editor: Science Direct
DOI: 10.1016/j.ijid.2022.12.018

Screening and vaccination against COVID-19 to minimize school closure: a modeling study

Autores: Elisabetta Colosi, Giulia Bassignana, Diego Andrés Contreras, Canelle Poirier, Pierre-Yves Boëlle, Simon Cauchemez, Yazdan Yazdanpanah, Bruno Lina, Arnaud Fontanet, Alain Barrat, Vittoria Colizza
Publicado en: Lancet Infectious Diseases, 2021
Editor: BMJ Yale
DOI: 10.1101/2021.08.15.21261243

Thrombosis pathways in COVID-19 vs. influenza-associated ARDS: A targeted proteomics approach

Autores: Emma Rademaker, Dennis J. Doorduijn, Nuray Kusadasi, Coen Maas, Julia Drylewicz, Albert Huisman, Imo E. Hoefer, Marc J. M. Bonten, Lennie P. G. Derde, Suzan H. M. Rooijakkers, Olaf L. Cremer
Publicado en: Journal of Thrombosis and Haemostasis, 2022
Editor: Wiley
DOI: 10.1111/jth.15671

Evaluation of a throat spray with lactobacilli in COVID-19 outpatients in a randomized, double-blind, placebo-controlled trial for symptom and viral load reduction

Autores: De Boeck I., Cauwenberghs E., Spacova I., Gehrmann T., Eilers T., Delanghe I., Wittouck S., Bron P.A., Henkens T., Gamgami I., Simons A., Claes I., Mariën J., Ariën K.K., Bakokimi D. , Loens K., Jacobs K., a Ieven M., Bruijning-Verhagen P., Delputte P., Coenen S., Verhoeven V., Lebeer S
Publicado en: Clinical Microbiology and Infection, 2022
Editor: BMJ Yale
DOI: 10.1101/2022.03.17.22272401

Point prevalence audit surveys of respiratory tract infection consultations and antibiotic prescribing in primary care before and during the COVID-19 pandemic in Ireland

Autores: Mala Shah, Aoife Fleming, Teresa Barbosa, Alike van der Velden, Sana Parveen, Akke Vellinga
Publicado en: Journal of Antimicrobial Chemotherapy, 2023
Editor: Oxford Academic
DOI: 10.1093/jac/dkad088

The Renin-Angiotensin System in Acute Lung Injury

Autores: Lawler, Patrick R., Derde, Lennie P. G., McVerry, Bryan J., Russell, James A., van de Veerdonk, Frank L
Publicado en: Critical Care Medicine, 2022
Editor: Society of Critical Care Medicine
DOI: 10.1097/ccm.0000000000005567

Monitoring the SARS-CoV-2 pandemic: screening algorithm with single nucleotide polymorphism detection for the rapid identification of established and emerging variants

Autores: Mertens J. Coppens J., Loens K., Le Mercier M., Xavier B. B., Lammens C., Vandamme S., Jansens H., Goossens H., and Matheeussen V
Publicado en: Clinical Microbiology and Infection, 2022
Editor: Elsevier
DOI: 10.1016/j.cmi.2021.09.007

A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures

Autores: Tran Kiem C, Massonnaud CR, Levy-Bruhl D, Poletto C, Colizza V, Bosetti P, Fontanet A, Gabet A, Olié V, Zanetti L, Boëlle PY, Crépey P, Cauchemez S
Publicado en: EClinicalMedicine, 2021
Editor: Lancet
DOI: 10.1016/j.eclinm.2021.101001

Clinical diagnosis of SARS-CoV-2 infection: An observational study of respiratory tract infection in primary care in the early phase of the pandemic

Autores: Alike W. van der Velden, Milensu Shanyinde, Emily Bongard, Femke Böhmer, Slawomir Chlabicz, Annelies Colliers, Ana García-Sangenís, Lile Malania, Jozsef Pauer, Angela Tomacinschii, Ly-Mee Yu, Katherine Loens, Margareta Ieven, Theo J. Verheij, Herman Goossens, Akke Vellinga, Christopher C. Butler
Publicado en: European Journal of General Practice, 2023
Editor: Taylor and Francis
DOI: 10.1080/13814788.2023.2270707

Randomised clinical trials in critical care: past, present and future

Autores: Anders Granholm, Waleed Alhazzani, Lennie P. G. Derde, Derek C. Angus, Fernando G. Zampieri, Naomi E. Hammond, Rob Mac Sweeney, Sheila N. Myatra, Elie Azoulay, Kathryn Rowan, Paul J. Young, Anders Perner & Morten Hylander Møller
Publicado en: Intensive Care Medicine, 2022
Editor: Springer
DOI: 10.1007/s00134-021-06587-9

From more testing to smart testing: data-guided SARS-CoV-2 testing choices, the Netherlands, May to September 2020

Autores: van Beek Janko, Igloi Zsofia, Boelsums Timo, Fanoy Ewout, Gotz Hannelore, Molenkamp Richard, van Kampen Jeroen, GeurtsvanKessel Corine, van der Eijk Annemiek A, van de Vijver David, Koopmans Marion
Publicado en: Eurosurveillance, 2022
Editor: Eurosurveillance
DOI: 10.2807/1560-7917.es.2022.27.8.2100702

Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021

Autores: Tran Kiem C, Andronico A, Bosetti P, Paireau J, Alter L, Boëlle PY, Fontanet A, Lévy-Bruhl D, Cauchemez S
Publicado en: Eurosurveillance, 2021
Editor: Eurosurveillance
DOI: 10.2807/1560-7917.es.2021.26.26.2100533

Transmission of SARS-CoV-2 within households: a prospective cohort study in the Netherlands and Belgium – Interim results

Autores: JDM Verberk, MLA de Hoog, I Westerhof, S Van Goethem, C Lammens, M Ieven, E de Bruin, J Bielicki, S Coenen, J van Beek, M Bonten, H Goossens, PCJL Bruijning-Verhagen
Publicado en: Medrxiv, 2021
Editor: BMJ Yale
DOI: 10.1101/2021.04.23.21255846

The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

Autores: J. Manry et al
Publicado en: Research Square, 2022
Editor: Research Square Company
DOI: 10.21203/rs.3.rs-1225906/v1

Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages

Autores: Touret F, Giraud E, Bourret J, Donati F, Tran-Rajau J, Chiaravalli J, Lemoine F, Agou F, Simon-Lorière E, van der Werf S, de Lamballerie X.
Publicado en: 2023
Editor: Science Direct
DOI: 10.1016/j.isci.2023.106413

Adherence and sustainability of interventions informing optimal control against the COVID-19 pandemic

Autores: Laura Di Domenico, Chiara E Sabbatini, Pierre-Yves Boëlle, Chiara Poletto, Pascal Crépey, Juliette Paireau, Simon Cauchemez, François Beck, Harold Noel, Daniel Lévy-Bruhl, Vittoria Colizza
Publicado en: Communications Medicine, 2021
Editor: Springer Nature
DOI: 10.1038/s43856-021-00057-5

Autores: Temmam S, Montagutelli X, Herate C, Donati F, Regnault B, Attia M, Baquero Salazar E, Chretien D, Conquet L, Jouvion G, Pipoli Da Fonseca J, Cokelaer T, Amara F, Relouzat F, Naninck T, Lemaitre J, Derreudre-Bosquet N, Pascal Q, Bonomi M, Bigot T, Munier S, Rey FA, Le Grand R, van der Werf S, Eloit M.
Publicado en: 2023
Editor: EMBO Press
DOI: 10.15252/embr.202256055

Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths

Autores: Bastard P et al
Publicado en: Science Immunology, 2021
Editor: American Association for the Advancement of Science
DOI: 10.1126/sciimmunol.abl4340

Reduced Seasonal Coronavirus Antibody Responses in Children Following COVID-19 Mitigation Measures, The Netherlands

Autores: Sikkema et al
Publicado en: Viruses, 2023
Editor: MDPI
DOI: 10.3390/v15010212

Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study

Autores: Mühlemann B, Thibeault C, Hillus D, Helbig ET, Lippert LJ, Tober-Lau P, Schwarz T, Müller MA; Pa-COVID-19 collaborative study group, Witzenrath M, Suttorp N, Sander LE, Drosten C, Jones TC, Corman VM, Kurth F
Publicado en: Clin Microbiol Infect, 2021
Editor: Elsevier
DOI: 10.1016/j.cmi.2021.06.008

Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19

Autores: Faucher et al
Publicado en: Nature Communications, 2022
Editor: Springer
DOI: 10.1038/s41467-022-29015-y

Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana

Autores: Andronico A, Tran Kiem C, Paireau J, Succo T, Bosettit P, Lefrancq N, Nacher M, Djossou F, Sanna A, Flamand C, Salje H, Rousseau C, Cauchemez S
Publicado en: Nature Communications, 2021
Editor: Nature Springer
DOI: 10.1038/s41467-021-21944-4

Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial

Autores: REMAP-CAP Writing Committee for the REMAP-CAP Investigators
Publicado en: JAMA, 2022
Editor: JAMA Network
DOI: 10.1001/jama.2022.2910

Following the science? Views from scientists on government advisory boards during the COVID-19 pandemic: a qualitative interview study in five European countries

Autores: Elien Colman, Marta Wanat, Herman Goossens, Sarah Tonkin-Crine, Sibyl Anthierens
Publicado en: BMJ Global Health, Edición 6/9, 2021, Página(s) e006928, ISSN 2059-7908
Editor: BMJ
DOI: 10.1136/bmjgh-2021-006928

International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020

Autores: Veerle Matheeussen, Victor M Corman, Oliver Donoso Mantke, Elaine McCulloch, Christine Lammens, Herman Goossens, Daniela Niemeyer, Paul S Wallace, Paul Klapper, Hubert GM Niesters, Christian Drosten, Margareta Ieven
Publicado en: Eurosurveillance, Edición 25/27, 2020, ISSN 1560-7917
Editor: Eurosurveillance
DOI: 10.2807/1560-7917.es.2020.25.27.2001223

Lockdown as a last resort option in case of COVID-19 epidemic rebound: a modelling study

Autores: Cécile Tran Kiem, Pascal Crépey, Paolo Bosetti, Daniel Levy Bruhl, Yazdan Yazdanpanah, Henrik Salje, Pierre-Yves Boëlle, Simon Cauchemez
Publicado en: Eurosurveillance, Edición 26/22, 2021, ISSN 1560-7917
Editor: Eurosurveillance
DOI: 10.2807/1560-7917.es.2021.26.22.2001536

Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020

Autores: Isabelle Sermet-Gaudelus, Sarah Temmam, Christèle Huon, Sylvie Behillil, Vincent Gajdos, Thomas Bigot, Thibaut Lurier, Delphine Chrétien, Marija Backovic, Agnès Delaunay-Moisan, Flora Donati, Mélanie Albert, Elsa Foucaud, Bettina Mesplées, Grégoire Benoist, Albert Faye, Marc Duval-Arnould, Célia Cretolle, Marina Charbit, Mélodie Aubart, Johanne Auriau, Mathie Lorrot, Dulanjalee Kariyawasam
Publicado en: Eurosurveillance, Edición 26/13, 2021, ISSN 1560-7917
Editor: Eurosurveillance
DOI: 10.2807/1560-7917.es.2021.26.13.2001782

Transformation of primary care during the COVID-19 pandemic: experiences of healthcare professionals in eight European countries

Autores: Marta Wanat, Melanie Hoste, Nina Gobat, Marilena Anastasaki, Femke Böhmer, Slawomir Chlabicz, Annelies Colliers, Karen Farrell, Maria-Nefeli Karkana, John Kinsman, Christos Lionis, Ludmila Marcinowicz, Katrin Reinhardt, Ingmarie Skoglund, Pär-Daniel Sundvall, Akke Vellinga, Theo JM Verheij, Herman Goossens, Christopher C Butler, Alike van der Velden, Sibyl Anthierens, Sarah Tonkin-Crine
Publicado en: British Journal of General Practice, Edición 71/709, 2021, Página(s) e634-e642, ISSN 0960-1643
Editor: Royal College of General Practitioners
DOI: 10.3399/bjgp.2020.1112

Monitoring approaches for health-care workers during the COVID-19 pandemic

Autores: Julia A Bielicki, Xavier Duval, Nina Gobat, Herman Goossens, Marion Koopmans, Evelina Tacconelli, Sylvie van der Werf
Publicado en: The Lancet Infectious Diseases, Edición 20/10, 2020, Página(s) e261-e267, ISSN 1473-3099
Editor: The Lancet Publishing Group
DOI: 10.1016/s1473-3099(20)30458-8

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

Autores: REMAP-CAP Investigators, Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AD, Arabi YM, Annane D, Beane A, van Bentum-Puijk W, Berry LR, Bhimani Z, Bonten MJM, Bradbury CA, Brunkhorst FM, Buzgau A, Cheng AC, Detry MA, Duffy EJ, Estcourt LJ, Fitzgerald M, Goossens H, Haniffa R, Higgins AM, Hills TE, Horvat CM, Lamontagne F, Lawler PR, Leavis HL, Linstrum KM, Litton E, Lorenzi E, Marshall JC, May
Publicado en: New England Journal of Medicine, Edición 384/16, 2021, Página(s) 1491-1502, ISSN 0028-4793
Editor: Massachusetts Medical Society
DOI: 10.1056/nejmoa2100433

Experiences and needs of persons living with a household member infected with SARS-CoV-2: A mixed method study

Autores: Janneke D. M. Verberk, Sibyl A. Anthierens, Sarah Tonkin-Crine, Herman Goossens, John Kinsman, Marieke L. A. de Hoog, Julia A. Bielicki, Patricia C. J. L. Bruijning-Verhagen, Nina H. Gobat
Publicado en: PLOS ONE, Edición 16/3, 2021, Página(s) e0249391, ISSN 1932-6203
Editor: Public Library of Science
DOI: 10.1371/journal.pone.0249391

A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection

Autores: Tingting Li, Hongmin Cai, Hebang Yao, Bingjie Zhou, Ning Zhang, Martje Fentener van Vlissingen, Thijs Kuiken, Wenyu Han, Corine H. GeurtsvanKessel, Yuhuan Gong, Yapei Zhao, Quan Shen, Wenming Qin, Xiao-Xu Tian, Chao Peng, Yanling Lai, Yanxing Wang, Cedric A. J. Hutter, Shu-Ming Kuo, Juan Bao, Caixuan Liu, Yifan Wang, Audrey S. Richard, Hervé Raoul, Jiaming Lan, Markus A. Seeger, Yao Cong, Barry R
Publicado en: Nature Communications, Edición 12/1, 2021, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-021-24905-z

Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020

Autores: Veerle Matheeussen, Katherine Loens, Christine Lammens, Tuba Vilken, Marion Koopmans, Herman Goossens, Margareta Ieven
Publicado en: Journal of Clinical Virology, Edición 128, 2020, Página(s) 104432, ISSN 1386-6532
Editor: Elsevier BV
DOI: 10.1016/j.jcv.2020.104432

Evaluating the effect of demographic factors, socioeconomic factors, and risk aversion on mobility during the COVID-19 epidemic in France under lockdown: a population-based study

Autores: Giulia Pullano, Eugenio Valdano, Nicola Scarpa, Stefania Rubrichi, Vittoria Colizza
Publicado en: The Lancet Digital Health, Edición 2/12, 2020, Página(s) e638-e649, ISSN 2589-7500
Editor: Elsevier BV
DOI: 10.1016/s2589-7500(20)30243-0

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

Autores: Ludivine Grzelak, Sarah Temmam, Cyril Planchais, Caroline Demeret, Laura Tondeur, Christèle Huon, Florence Guivel-Benhassine, Isabelle Staropoli, Maxime Chazal, Jeremy Dufloo, Delphine Planas, Julian Buchrieser, Maaran Michael Rajah, Remy Robinot, Françoise Porrot, Mélanie Albert, Kuang-Yu Chen, Bernadette Crescenzo-Chaigne, Flora Donati, François Anna, Philippe Souque, Marion Gransagne, Jacqu
Publicado en: Science Translational Medicine, Edición 12/559, 2020, Página(s) eabc3103, ISSN 1946-6234
Editor: American Association for the Advancement of Science
DOI: 10.1126/scitranslmed.abc3103

High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort

Autores: Sarah Tubiana, Charles Burdet, Nadhira Houhou, Michael Thy, Pauline Manchon, François Blanquart, Charlotte Charpentier, Jérémie Guedj, Loubna Alavoine, Sylvie Behillil, Anne Leclercq, Jean-Christophe Lucet, Yazdan Yazdanpanah, Mikaël Attia, Caroline Demeret, Thierry Rose, Julia Anna Bielicki, Patricia Bruijning-Verhagen, Herman Goossens, Diane Descamps, Sylvie van der Werf, Bruno Lina, Xavier
Publicado en: Journal of Infection, Edición 82/5, 2021, Página(s) 186-230, ISSN 0163-4453
Editor: W. B. Saunders Co., Ltd.
DOI: 10.1016/j.jinf.2021.01.026

Primary care for patients with respiratory tract infection before and early on in the COVID-19 pandemic: an observational study in 16 European countries

Autores: Alike W van der Velden, Eva A Bax, Emily Bongard, Rune Munck Aabenhus, Marilena Anastasaki, Sibyl Anthierens, Anca Balan, Femke Böhmer, Pascale Bruno, Slawomir Chlabicz, Samuel Coenen, Annelies Colliers, Susanne Emmerich, Ana Garcia-Sangenis, Hrachuhi Ghazaryan, Sanne R van der Linde, Lile Malania, József Pauer, Angela Tomacinschii, Sarah Tonkin-Crine, Akke Vellinga, Ihor Zastavnyy, Theo Verheij
Publicado en: BMJ Open, Edición 11/7, 2021, Página(s) e049257, ISSN 2044-6055
Editor: BMJ Publishing Group
DOI: 10.1136/bmjopen-2021-049257

Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics

Autores: Simon Schroeder, Fabian Pott, Daniela Niemeyer, Talitha Veith, Anja Richter, Doreen Muth, Christine Goffinet, Marcel A Müller, Christian Drosten
Publicado en: The Lancet Microbe, 2021, ISSN 2666-5247
Editor: Elsevier BV
DOI: 10.1016/s2666-5247(21)00027-6

Performance of the FREND™ COVID-19 IgG/IgM Duo point-of-care test for SARS-CoV-2 antibody detection

Autores: Dorien G. De Munck, Bart Peeters, Evelyne Huyghe, Herman Goossens, Margareta Ieven, Veerle Matheeussen
Publicado en: Acta Clinica Belgica, 2021, Página(s) 1-6, ISSN 1784-3286
Editor: Taylor & Francis Production
DOI: 10.1080/17843286.2021.1940776

Face coverings for covid-19: from medical intervention to social practice

Autores: Helene-Mari van der Westhuizen, Koot Kotze, Sarah Tonkin-Crine, Nina Gobat, Trisha Greenhalgh
Publicado en: BMJ, 2020, Página(s) m3021, ISSN 1756-1833
Editor: BMJ
DOI: 10.1136/bmj.m3021

Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

Autores: Jeroen J. A. van Kampen, David A. M. C. van de Vijver, Pieter L. A. Fraaij, Bart L. Haagmans, Mart M. Lamers, Nisreen Okba, Johannes P. C. van den Akker, Henrik Endeman, Diederik A. M. P. J. Gommers, Jan J. Cornelissen, Rogier A. S. Hoek, Menno M. van der Eerden, Dennis A. Hesselink, Herold J. Metselaar, Annelies Verbon, Jurriaan E. M. de Steenwinkel, Georgina I. Aron, Eric C. M. van Gorp, Sander
Publicado en: Nature Communications, Edición 12/1, 2021, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-020-20568-4

Model-based evaluation of school- and non-school-related measures to control the COVID-19 pandemic

Autores: Ganna Rozhnova, Christiaan H. van Dorp, Patricia Bruijning-Verhagen, Martin C. J. Bootsma, Janneke H. H. M. van de Wijgert, Marc J. M. Bonten, Mirjam E. Kretzschmar
Publicado en: Nature Communications, Edición 12/1, 2021, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-021-21899-6

Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study

Autores: Victor M Corman, Verena Claudia Haage, Tobias Bleicker, Marie Luisa Schmidt, Barbara Mühlemann, Marta Zuchowski, Wendy K Jo, Patricia Tscheak, Elisabeth Möncke-Buchner, Marcel A Müller, Andi Krumbholz, Jan Felix Drexler, Christian Drosten
Publicado en: The Lancet Microbe, 2021, ISSN 2666-5247
Editor: Elsevier BV
DOI: 10.1016/s2666-5247(21)00056-2

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans

Autores: Bas B. Oude Munnink, Reina S. Sikkema, David F. Nieuwenhuijse, Robert Jan Molenaar, Emmanuelle Munger, Richard Molenkamp, Arco van der Spek, Paulien Tolsma, Ariene Rietveld, Miranda Brouwer, Noortje Bouwmeester-Vincken, Frank Harders, Renate Hakze-van der Honing, Marjolein C. A. Wegdam-Blans, Ruth J. Bouwstra, Corine GeurtsvanKessel, Annemiek A. van der Eijk, Francisca C. Velkers, Lidwien A. M. Sm
Publicado en: Science, Edición 371/6525, 2021, Página(s) 172-177, ISSN 0036-8075
Editor: American Association for the Advancement of Science
DOI: 10.1126/science.abe5901

Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-2

Autores: Zsófia Iglói, Margareta leven, Zain Abdel-Karem Abou-Nouar, Babette Weller, Veerle Matheeussen, Jasmine Coppens, Marion Koopmans, Richard Molenkamp
Publicado en: Journal of Clinical Virology, Edición 129, 2020, Página(s) 104510, ISSN 1386-6532
Editor: Elsevier BV
DOI: 10.1016/j.jcv.2020.104510

Tracing and analysis of 288 early SARS-CoV-2 infections outside China: A modeling study

Autores: Francesco Pinotti, Laura Di Domenico, Ernesto Ortega, Marco Mancastroppa, Giulia Pullano, Eugenio Valdano, Pierre-Yves Boëlle, Chiara Poletto, Vittoria Colizza
Publicado en: PLOS Medicine, Edición 17/7, 2020, Página(s) e1003193, ISSN 1549-1676
Editor: PLOS Medicine
DOI: 10.1371/journal.pmed.1003193

Buscando datos de OpenAIRE...

Resultado final

Publicaciones

Compartir esta página

Descargar